0001178913-12-003049.txt : 20121106 0001178913-12-003049.hdr.sgml : 20121106 20121106172300 ACCESSION NUMBER: 0001178913-12-003049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120822 FILED AS OF DATE: 20121106 DATE AS OF CHANGE: 20121106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sank Leonard CENTRAL INDEX KEY: 0001416089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50298 FILM NUMBER: 121184142 MAIL ADDRESS: STREET 1: 3 BLAIR ROAD CITY: CAPE TOWN STATE: T3 ZIP: 8005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001176309 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980376008 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 2 ELZA STREET CITY: JERUSALEM STATE: L3 ZIP: 93706 BUSINESS PHONE: 011 972-54-7909058 MAIL ADDRESS: STREET 1: 2 ELZA STREET CITY: JERUSALEM STATE: L3 ZIP: 93706 FORMER COMPANY: FORMER CONFORMED NAME: Integrated Security Technologies, Inc. DATE OF NAME CHANGE: 20040614 FORMER COMPANY: FORMER CONFORMED NAME: IGUANA VENTURES LTD DATE OF NAME CHANGE: 20020625 4 1 zk1212211.xml OWNERSHIP DOCUMENT X0306 4 2012-08-22 0 0001176309 ORAMED PHARMACEUTICALS INC. ORMP.OB 0001416089 Sank Leonard 3 BLAIR ROAD CAPE TOWN T3 8005 SOUTH AFRICA 1 0 0 0 Common Stock 2012-08-22 4 A 0 270270 0.2717 A 2627920 D Common Stock 2012-11-02 4 A 0 135135 0.2717 A 2763055 D Common Stock 937500 I See Footnote Common Stock 1666667 I See Footnote Warrant (right to buy) 0.50 2012-08-22 4 A 0 135135 0.0983 A 2017-08-22 Common Stock 135135 135135 D Warrant (right to buy) 0.50 2012-11-02 4 A 0 67568 0.0983 A 2017-11-02 Common Stock 67568 67568 D Includes 937,500 shares of common stock held by Mr. Sank's wife. Mr. Sank disclaims beneficial ownership of such securities. Includes 1,666,667 shares of common stock owned by a company wholly owned by a trust of which Mr. Sank is a trustee. Mr. Sank disclaims beneficial ownership of such securities. The warrant was fully vested on the date of issuance. The shares and warrants were purchased as "units" at a price per unit of $0.37 in connection with the Issuer's 2012 private placement. The consideration was allocated to the shares and warrants based on relative fair value. The value allocated to the warrants was estimated by using the Black Scholes option-pricing model. /s/ Leonard Sank 2012-11-06